Because for decades, pregnancy has been treated as a research risk – not a design priority.

Pregnant women are routinely excluded from clinical trials.
Animal models (still the default) can’t reliably predict how drugs cross the human placenta.
And ethical barriers have blocked direct study of fetal exposure.

This leaves pharma teams navigating one of the most complex physiological systems – the placenta – with almost no human-specific data.

Enter the LIFESAVER Project.

We’ve built a bio-digital placenta clone comprising:
– A microfluidic model that mimics early pregnancy conditions
– Human-derived cell cultures, instead of animal surrogates
– In silico computer tools that simulate drug transport and fetal exposure

The goal? To give drug developers predictive, human-relevant safety data before clinical trials ever begin.

If you’re building drugs for reproductive-age populations, it’s time to rethink how you assess fetal risk.

Learn more: www.lifesaverproject.eu